Linda Crnic Institute Lectures: “DNA Methylation in Down Syndrome: A Possible Therapeutic Target”

Ben Tycko, MD, PhD

Professor of Pathology, Columbia University
December 7, 2011

Dr. Tycko’s lab is pursuing several different lines of research:

1) the epigenetics and genetics of Wilms tumors, acute myeloid leukemias, and other human cancers;
2) the identities and the physiological functions of imprinted genes;
3) the genetic and epigenetic basis for phenotypes in Down syndrome. His lab also collaborates with others at Columbia to study the population genetics of Alzheimer’s disease.

• Linda Crnic Institute Lectures: “Aberrant Hematopoiesis in Children with Down syndrome”
• Linda Crnic Institute Lectures: “Consequences of Aneuploidy”
• Linda Crnic Institute Lectures: “DNA Methylation in Down Syndrome: A Possible Therapeutic Target”
• Linda Crnic Institute Lectures: “Studying Mechanism and Medicine in Down syndrome and Alzheimer’s Disease using C. elegans“
• Linda Crnic Institute Lectures: “The Neurobiology of Down Syndrome: A Case of Double Trouble”
• Linda Crnic Institute Lectures: “The Unique Clinical and Biological Features of Leukemias in Children with Down syndrome”
• Linda Crnic Institute Lectures: “Theory to Therapeutics in Mice and Men with Down Syndrome”
• Linda Crnic Institute Lectures: “Trisomy 21: Causes and Consequences”